Regulatory Approval for Elekta’s Acquisition of Nucletron Corporation

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: The Elekta group will provide improved value for cancer patients and health care providers, by addressing a broader range of cancers, in different body sites, and across a broader range of disease stages.

MORE ON THIS TOPIC